McNeeley D F, Brown A E, Noel G J, Chung M, De Lencastre H
Division of Pediatric Infectious Diseases, The New York Hospital-Cornell Medical Center, NY 10021, USA.
Pediatr Infect Dis J. 1998 Mar;17(3):184-8. doi: 10.1097/00006454-199803000-00003.
Between 1990 to 1992 and 1993 to 1995 there was a >5-fold increase (16.7% to 89.8%) in vancomycin-resistant Enterococcus faecium isolates as a percentage of all isolates of vancomycin-resistant enterococci on the pediatric units of The New York Hospital-Cornell Medical Center (NYH-CMC). A molecular epidemiologic investigation was undertaken to determine the extent to which this increase was associated with the spread of a vanA-containing clone of vancomycin-resistant E. faecium that had been previously defined in adults hospitalized at NYH-CMC or with the spread of another vanA clone that had been defined in children hospitalized on the pediatric service at Memorial Sloan-Kettering Cancer Center, which shares a common pediatric intensive care unit and pediatric house staff with NYH-CMC.
Molecular genotyping of vancomycin-resistant E. faecium isolates obtained from pediatric patients from 1993 to 1995 was performed by pulsed field gel electrophoresis of chromosomal SmaI digests. Southern hybridization was performed using vanA- and vanB-specific probes. Medical records of patients were reviewed for pertinent clinical and demographic information.
A single vanB clone of vancomycin-resistant E. faecium was responsible for 17 (77.3%) of 22 isolates in the neonatal intensive care unit (NICU) of NYH-CMC. Two other vanB strains of vancomycin-resistant E. faecium and 2 vanA strains were identified among the 5 remaining NICU isolates. Vancomycin-resistant E. faecium isolates from the other pediatric units represented a heterogeneous population of primarily vanA strains, but vanA clonal strains previously identified from patients on adult services at NYH-CMC and from children hospitalized at Memorial Sloan-Kettering Cancer Center were not detected.
A newly identified vanB clone was responsible for the increase in vancomycin-resistant E. faecium isolates in the NICU of NYH-CMC. The increase of vancomycin-resistant E. faecium among children hospitalized at NYH-CMC was unrelated to the spread of vancomycin-resistant E. faecium among adults in the same hospital or among children at an affiliated facility cared for by the same house staff and sharing a common pediatric intensive care unit.
在1990年至1992年以及1993年至1995年期间,纽约医院-康奈尔医学中心(NYH-CMC)儿科病房中,耐万古霉素屎肠球菌分离株占所有耐万古霉素肠球菌分离株的百分比增长了5倍多(从16.7%增至89.8%)。开展了一项分子流行病学调查,以确定这种增长在多大程度上与之前在NYH-CMC住院成人中定义的含vanA的耐万古霉素屎肠球菌克隆的传播有关,或者与在纪念斯隆-凯特琳癌症中心儿科住院儿童中定义的另一种vanA克隆的传播有关,该中心与NYH-CMC共用一个儿科重症监护病房和儿科住院医师。
对1993年至1995年从儿科患者中获得的耐万古霉素屎肠球菌分离株进行分子基因分型,采用染色体SmaI酶切产物的脉冲场凝胶电泳。使用vanA和vanB特异性探针进行Southern杂交。查阅患者病历以获取相关临床和人口统计学信息。
在NYH-CMC新生儿重症监护病房(NICU)的22株分离株中,单一的耐万古霉素屎肠球菌vanB克隆占17株(77.3%)。在其余5株NICU分离株中鉴定出另外2株耐万古霉素屎肠球菌vanB菌株和2株vanA菌株。来自其他儿科病房的耐万古霉素屎肠球菌分离株主要是vanA菌株的异质群体,但未检测到之前在NYH-CMC成人科室患者和纪念斯隆-凯特琳癌症中心住院儿童中鉴定出的vanA克隆菌株。
新鉴定出的vanB克隆导致了NYH-CMC新生儿重症监护病房中耐万古霉素屎肠球菌分离株的增加。在NYH-CMC住院儿童中耐万古霉素屎肠球菌的增加与同一医院成人中耐万古霉素屎肠球菌的传播或由同一住院医师护理且共用一个儿科重症监护病房的附属机构儿童中耐万古霉素屎肠球菌的传播无关。